Together with these findings, the facts that HIF-1α induces numerous hypoxic target genes which are involved in hepatic inflammation, cirrhosis and cancer imply that CDCA and guggulsterone can alleviate such hepatic diseases by inhibiting HIF-1α. The gene discussed is HIF1A; the disease is liver disorder.